3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Metabolic and Systemic Heart Diseases
Metabolic and systemic heart diseases represent a complex intersection of multiple physiological systems, where conditions such as diabetes, obesity, and hypertension can significantly impact cardiovascular health. These systemic diseases often lead to changes in heart function, contributing to conditions like heart failure, coronary artery disease, and arrhythmias. Understanding the links between metabolic imbalances and cardiovascular outcomes is crucial for developing effective treatment strategies. Metabolic and systemic heart diseases require a multidisciplinary approach that combines pharmacological interventions, lifestyle modifications, and targeted therapies to address the root causes. By focusing on managing underlying metabolic conditions, healthcare providers can significantly reduce the risk of heart-related complications and improve long-term cardiovascular health.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain